Page 322 - Read Online

Chen et al. Hepatoma Res 2018;4:29 I http://dx.doi.org/10.20517/2394-5079.2018.18 Page 13 of 15

62. Chen J, Rajasekaran M, Xia H, Zhang X, Kong S, Sekar K, Seshachalam V, Deivasigamani A, Goh B, Ooi L, Hong W, Hui K. The
microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin
signalling pathway. Gut 2016;65:1522-34.
63. Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016;64:S84-101.
64. Liang Y, Feng Y, Zong M, Wei X, Lee J, Feng Y, Li H, Yang G, Wu ZJ, Fu XD. β-catenin deficiency in hepatocytes aggravates
hepatocarcinogenesis driven by oncogenic β-catenin and MET. Hepatology 2018;67:1807-22.
65. Yin Y, Li F, Li S, Cai J, Shi J, Jiang Y. TLR4 Influences hepatitis B virus related hepatocellular carcinoma by regulating the Wnt/β-catenin
pathway. Cell Physiol Biochem 2017;42:469-79.
66. Wang S, Song K, Srivastava R, Dong C, Go G, Li N, Iwakiri Y, Mani A. Nonalcoholic fatty liver disease induced by noncanonical Wnt
and its rescue by Wnt3a. FASEB J 2015;29:3436-45.
67. Kyriakis J, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol
Rev 2012;92:689-737.
68. Pu W, Li J, Zheng Y, Shen X, Fan X, Zhou J, He J, Deng Y, Liu X, Wang C, Yang S, Chen Q, Liu L, Zhang G, Wei Y, Peng Y. Targeting
Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development. Hepatology 2018; doi:
10.1002/hep.29819.
69. Zhang R, Cao Y, Bai L, Zhu C, Li R, He H, Liu Y, Wu K, Liu F, Wu J. The collagen triple helix repeat containing 1 facilitates hepatitis
B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades. Mol Carcinog
2015;54:1554-66.
70. Zhang Y, Wei Y, Li X, Liang X, Wang L, Song J, Zhang X, Zhang C, Niu J, Zhang P, Ren Z, Tang B. microRNA-874 suppresses tumor
proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway. Cell Death Dis 2018;9:130.
71. Pinna F, Bissinger M, Beuke K, Huber N, Longerich T, Kummer U, Schirmacher P, Sahle S, Breuhahn K. A20/TNFAIP3 discriminates
tumor necrosis factor (TNF)-induced NF-κB from JNK pathway activation in hepatocytes. Front Physiol 2017;8:610.
72. Stebbins J, De S, Machleidt T, Becattini B, Vazquez J, Kuntzen C, Chen L, Cellitti J, Riel-Mehan M, Emdadi A, Solinas G,
Karin M, Pellecchia M. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc Natl Acad Sci U S A
2008;105:16809-13.
73. Nagata H, Hatano E, Tada M, Murata M, Kitamura K, Asechi H, Narita M, Yanagida A, Tamaki N, Yagi S, Ikai I, Matsuzaki K, Uemoto
S. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular
carcinoma. Hepatology 2009;49:1944-53.
74. Wu H, Tang X, Liu H, Mao X, Wang Y. Both classic Gs-cAMP/PKA/CREB and alternative Gs-cAMP/PKA/p38β/CREB signal
pathways mediate exenatide-stimulated expression of M2 microglial markers. J Neuroimmunol 2018;316:17-22.
75. Yang S, Dong S, Qu X, Zhong X, Zhang Q. Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/
p16 pathway in NSCLC. Mol Med Rep 2017;15:719-23.
76. Rudalska R, Dauch D, Longerich T, McJunkin K, Wuestefeld T, Kang T-W, Hohmeyer A, Pesic M, Leibold J, Von Thun A. In vivo
RNAi screening identifies a mechanism of sorafenib resistance in liver cancer. Nat Med 2014;20:1138.
77. Verma A, Singh D, Anwar F, Bhatt P, Al-Abbasi F, Kumar V. Triterpenoids principle of Wedelia calendulacea attenuated
diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB
pathway. Inflammopharmacology 2018;26:133-46.
78. Dai W, Wu J, Zhang S, Shi B, Xu X, Wang D, Wang J. Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2.
Int J Biochem Cell Biol 2017;89:157-70.
79. Sghaier I, Mouelhi L, Rabia N, Alsaleh B, Ghazoueni E, Almawi W, Loueslati B. Genetic variants in IL-6 and IL-10 genes and
susceptibility to hepatocellular carcinoma in HCV infected patients. Cytokine 2017;89:62-7.
80. Marquardt J, Gomez-Quiroz L, Arreguin Camacho L, Pinna F, Lee Y, Kitade M, Domínguez M, Castven D, Breuhahn K, Conner E,
Galle P, Andersen J, Factor V, Thorgeirsson S. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features
in liver cancer. J Hepatol 2015;63:661-9.
81. Ren L, Li Z, Dai C, Zhao D, Wang Y, Ma C, Liu C. Chrysophanol inhibits proliferation and induces apoptosis through NF-κB/cyclin D1
and NF-κB/Bcl-2 signaling cascade in breast cancer cell lines. Mol Med Rep 2018;17:4376-82.
82. Liang J, Dou Y, Wu X, Li H, Wu J, Huang Q, Luo D, Yi T, Liu Y, Su Z, Chen J. Protective effect of patchoulene epoxide against
ethanol-induced gastric ulcer in rats: influence on oxidative stress, inflammation and apoptosis. Chem Biol Interact 2018;283:30-7.
83. Tsai J, Pan P, Hsu F. Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular
carcinoma cells. Oncol Rep 2017;37:1036-44.
84. Yu X, Lan P, Hou X, Han Q, Lu N, Li T, Jiao C, Zhang J, Zhang C, Tian Z. HBV inhibits LPS-induced NLRP3 inflammasome activation
and IL-1β production via suppressing the NF-κB pathway and ROS production. J Hepatol 2017;66:693-702.
85. Best B, Moran P, Ren B. VEGF/PKD-1 signaling mediates arteriogenic gene expression and angiogenic responses in reversible human
microvascular endothelial cells with extended lifespan. Mol Cell Biochem 2018; doi: 10.1007/s11010-018-3286-z.
86. Han J, Ma Z, Gao P, Lu Z, Liu H, Gao L, Lu W, Ju X, Lv F, Zhao H, Bie X. The antibacterial activity of LI-F type peptide against
methicillin-resistant Staphylococcus aureus (MRSA) in vitro and inhibition of infections in murine scalded epidermis. Appl Microbiol
Biotechnol 2018;102:2301-11.
87. Choi S, Han H, Kim W, Song T, Choi S. VEGF overexpression predicts poor survival in hepatocellular carcinoma. Open Med (Wars)
2017;12:430-9.
88. Li X, Zhang D, Guan S, Ye W, Liu L, Lou L. Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a
systematic review. Oncotarget 2017;8:93179-85.